Alamar Biosciences Inc (ALMR) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Alamar Biosciences Inc   (ALMR)
 

Alamar Biosciences Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, Alamar Biosciences Inc 's inventory turnover ratio sequentially decreased to 0.98 in the third quarter 2026, otherwise the ratio remained above the average, as ALMR's markets remain strong.Alamar Biosciences Inc 's average inventory processing period in the Sep 30 2026 quarter, has increased to 372 days, from 294 days, in the Jun 30 2026 quarter.

Within Healthcare sector Alamar Biosciences Inc achieved the highest inventory turnover ratio. While inventory turnover ranking remained unchanged in the Third Quarter 2026 compared to previous quarter at no. .

ALMR Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Alamar Biosciences Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ALMR Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth - - - - -
Y / Y Cost of Sales Growth 70.18 % 74.71 % - - -
Inventory Turnover Ratio (TTM) 0.98 1.24 1.7 2.32 -
ALMR's Total Ranking # # # # #
Average inventory processing period 372 295 215 157 -
Seq. Inventory Growth 19.21 % 13.72 % 3.77 % - -
Seq. Cost of Sales Growth 10.18 % 6.45 % 37.23 % 5.74 % 13.12 %




Inventory Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #
Healthcare Sector #
Overall Market #

Inventory Turnover Ratio Statistics
High Average Low
0 0 0
 



ALMR Company Profile >> Back to ALMR Efficiency Comparisons >> Compare ALMR Inventory Turnover Ratio to its Competitors

Financial Statements
Alamar Biosciences Inc 's Inventories $ 54 Millions Visit ALMR's Balance sheet
Alamar Biosciences Inc 's Cost of Revenues TTM $ 44 Millions Visit ALMR's Income Statement
What are ALMR's Sales? Visit ALMR's Sales by Segment

Other Inventory Turnover Ratios
Alamar Biosciences Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ALMR's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ALMR's Competitors
Inventory Turnover Ratio for ALMR's Suppliers
Inventory Turnover Ratio for ALMR's Customers

You may also want to know
ALMR's Sales Growth Rates ALMR's Pe Price to earnings ratio ALMR's Receivables Turnover Ratio ALMR's Stock Quote
ALMR's Net Income Growth Rates ALMR's Ps Price to Sales ratio ALMR's Sales per Employee ALMR's Asset Turnover Ratio
ALMR's Net Margin ALMR's Pb Price to Book ratio ALMR's Financial Strength Ratios ALMR's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Johnson and Johnson  2.17 $ 32,222.000  Millions$ 14,824  Millions
Orasure Technologies Inc  2.17 $ 66.055  Millions$ 30  Millions
Standard Biotools Inc   2.16 $ 39.539  Millions$ 18  Millions
Adc Therapeutics Sa  2.14 $ 5.857  Millions$ 3  Millions
Icu Medical Inc  2.14 $ 1,304.538  Millions$ 609  Millions
Glaukos Corp  2.13 $ 131.180  Millions$ 62  Millions
Halozyme Therapeutics Inc   2.13 $ 319.654  Millions$ 150  Millions
Organon and Co   2.08 $ 2,859.000  Millions$ 1,371  Millions
Repligen Corp  2.07 $ 372.472  Millions$ 180  Millions
Boston Scientific Corporation  2.06 $ 6,502.000  Millions$ 3,153  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  2.03 $ 16.819  Millions$ 8  Millions
Bausch and Lomb Corp  2.01 $ 1,986.000  Millions$ 990  Millions
Clearpoint Neuro Inc   1.98 $ 17.564  Millions$ 9  Millions
Alpha Pro Tech Ltd   1.97 $ 40.363  Millions$ 21  Millions
Intuitive Surgical Inc   1.91 $ 3,799.300  Millions$ 1,986  Millions
Indivior Pharmaceuticals Inc   1.88 $ 208.000  Millions$ 111  Millions
Tenet Healthcare Corp  1.88 $ 642.000  Millions$ 342  Millions
Trisalus Life Sciences Inc   1.86 $ 7.291  Millions$ 4  Millions
Elutia Inc   1.84 $ 3.772  Millions$ 2  Millions
Amgen Inc   1.81 $ 11,319.000  Millions$ 6,255  Millions
Haemonetics Corporation  1.80 $ 558.423  Millions$ 310  Millions
Orthofix Medical Inc   1.78 $ 244.423  Millions$ 137  Millions
Iradimed Corporation  1.78 $ 21.878  Millions$ 12  Millions
Harvard Bioscience Inc   1.76 $ 38.986  Millions$ 22  Millions
Ceribell Inc   1.74 $ 12.160  Millions$ 7  Millions
Axsome Therapeutics Inc   1.67 $ 58.422  Millions$ 35  Millions
Ocular Therapeutix Inc   1.66 $ 6.389  Millions$ 4  Millions
Insmed Inc  1.66 $ 237.067  Millions$ 143  Millions
Stryker Corp  1.66 $ 9,116.000  Millions$ 5,499  Millions
Bruker Corporation  1.66 $ 1,838.200  Millions$ 1,110  Millions

Date modified: 2026-11-06T13:07:27+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.